Also, the survival rate after initial diagnosis of metastatic non-small-cell lung cancer patients harboring RBM10 mutants was lower than that with wild-type RBM10 (27, 28) (SI Appendix, Fig. S1B), suggesting that RBM10 mutants deserve more attention. The gene discussed is RBM10; the disease is non-small cell lung carcinoma.